• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性HIV-1和感染性分子克隆对广泛中和抗体的敏感性存在差异。

Primary HIV-1 and Infectious Molecular Clones Are Differentially Susceptible to Broadly Neutralizing Antibodies.

作者信息

Kim Jiae, Rao Venigalla B, Rao Mangala

机构信息

US Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD 20817, USA.

Laboratory of Adjuvant and Antigen Research, US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

出版信息

Vaccines (Basel). 2020 Dec 21;8(4):782. doi: 10.3390/vaccines8040782.

DOI:10.3390/vaccines8040782
PMID:33371189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7767270/
Abstract

To prevent the spread of HIV-1, a vaccine should elicit antibodies that block viral entry for all cell types. Recently, we have developed a virus capture assay to quantitatively examine early time points of infection. Here we present data on the ability of bNAbs to inhibit capture (1 h) or replication (48 h) of purified primary acute or chronic HIV or infectious molecular clones (IMCs) in human peripheral blood mononuclear cells (PBMCs) as quantified by qRT-PCR. Although bNAbs significantly inhibited HIV-1 replication in PBMCs in a virus subtype and in a PBMC-donor specific manner, they did not inhibit virus capture of primary viruses. In contrast, IMC capture and replication in PBMCs and purified CD4 T cells were significantly inhibited by bNAbs, thus indicating that unlike IMCs, primary HIV-1 may initially bind to other cell surface molecules, which leads to virus capture even in the presence of bNAbs. Our results demonstrate that the initial interactions and some aspects of infectivity of primary HIV-1 and IMCs are inherently different, which underscores the importance of studying virus transmission using primary viruses in studies, an issue that could impact HIV-1 vaccine design strategies.

摘要

为防止HIV-1传播,疫苗应诱导产生能阻断所有细胞类型病毒进入的抗体。最近,我们开发了一种病毒捕获检测方法,用于定量检测感染的早期时间点。在此,我们展示了关于广谱中和抗体(bNAbs)抑制人外周血单核细胞(PBMCs)中纯化的原发性急性或慢性HIV或感染性分子克隆(IMCs)捕获(1小时)或复制(48小时)能力的数据,该数据通过qRT-PCR进行定量。尽管bNAbs以病毒亚型和PBMC供体特异性方式显著抑制PBMCs中的HIV-1复制,但它们并未抑制原发性病毒的病毒捕获。相比之下,bNAbs显著抑制了PBMCs和纯化的CD4 T细胞中IMCs的捕获和复制,这表明与IMCs不同,原发性HIV-1最初可能与其他细胞表面分子结合,即使在存在bNAbs的情况下也会导致病毒捕获。我们的结果表明,原发性HIV-1和IMCs的初始相互作用及感染性的某些方面存在本质差异,这突出了在研究中使用原发性病毒研究病毒传播的重要性,这一问题可能会影响HIV-1疫苗设计策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/dde43cf7bac9/vaccines-08-00782-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/df6168b26f8b/vaccines-08-00782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/d79c5f4aa6d9/vaccines-08-00782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/89dde60f5f3f/vaccines-08-00782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/2074395f1d5e/vaccines-08-00782-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/dde43cf7bac9/vaccines-08-00782-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/df6168b26f8b/vaccines-08-00782-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/d79c5f4aa6d9/vaccines-08-00782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/89dde60f5f3f/vaccines-08-00782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/2074395f1d5e/vaccines-08-00782-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f880/7767270/dde43cf7bac9/vaccines-08-00782-g005.jpg

相似文献

1
Primary HIV-1 and Infectious Molecular Clones Are Differentially Susceptible to Broadly Neutralizing Antibodies.原发性HIV-1和感染性分子克隆对广泛中和抗体的敏感性存在差异。
Vaccines (Basel). 2020 Dec 21;8(4):782. doi: 10.3390/vaccines8040782.
2
Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.定量分析揭示了HIV-1原病毒和假病毒对广泛中和抗体捕获的不同敏感性。
Virology. 2017 Aug;508:188-198. doi: 10.1016/j.virol.2017.05.015. Epub 2017 May 31.
3
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.针对具有传播奠基者Env的HIV-1细胞间传播的广谱中和抗体的效力降低及中和不完全
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02425-16. Print 2017 May 1.
4
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.广泛中和性抗HIV-1抗体对在外周血单核细胞中产生的B亚型临床分离株的中和活性
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01883-17. Print 2018 Mar 1.
5
A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.婴儿来源的 HIV-1 包膜糖蛋白中的一个罕见突变改变了二聚体间的稳定性,并影响了针对三聚体顶部的广谱中和抗体的敏感性。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00814-20.
6
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.用于评估疫苗诱导的抗体依赖的细胞毒性介导抗体的标准化评估的 HIV 包膜株的选择。
J Virol. 2022 Jan 26;96(2):e0164321. doi: 10.1128/JVI.01643-21. Epub 2021 Nov 3.
7
Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.广泛中和抗体抑制HIV-1细胞间传播的能力具有毒株和表位依赖性。
PLoS Pathog. 2015 Jul 9;11(7):e1004966. doi: 10.1371/journal.ppat.1004966. eCollection 2015 Jul.
8
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.广泛中和抗体在预防HIV-1感染黏膜组织方面显示出优于非中和抗体的潜力。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01762-16. Print 2017 Jan 1.
9
Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1.在两名感染1型人类免疫缺陷病毒的受试者感染早期,广泛中和抗体的出现及病毒的共同进化
J Virol. 2014 Nov;88(22):12968-81. doi: 10.1128/JVI.01816-14. Epub 2014 Aug 13.
10
Single-Chain Variable Fragments of Broadly Neutralizing Antibodies Prevent HIV Cell-Cell Transmission.单链可变片段抗体可预防 HIV 细胞间传播。
J Virol. 2022 Feb 23;96(4):e0193421. doi: 10.1128/jvi.01934-21. Epub 2021 Dec 22.

本文引用的文献

1
Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET.将 HIV-1 包膜糖蛋白结构与单分子荧光共振能量转移观察到的病毒状态相关联。
Nature. 2019 Apr;568(7752):415-419. doi: 10.1038/s41586-019-1101-y. Epub 2019 Apr 10.
2
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.HIV包膜糖型异质性和局部多样性决定V2顶端广泛中和抗体谱系的起始和成熟。
Immunity. 2017 Nov 21;47(5):990-1003.e9. doi: 10.1016/j.immuni.2017.11.002.
3
Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.
包膜蛋白的糖基化和寡聚状态可能会影响α4β7整合素对HIV-1病毒体的捕获。
Virology. 2017 Aug;508:199-212. doi: 10.1016/j.virol.2017.05.016. Epub 2017 May 31.
4
Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.定量分析揭示了HIV-1原病毒和假病毒对广泛中和抗体捕获的不同敏感性。
Virology. 2017 Aug;508:188-198. doi: 10.1016/j.virol.2017.05.015. Epub 2017 May 31.
5
Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus.抗体介导的针对猿猴-人免疫缺陷病毒攻击的保护作用包括对远端病毒的全身清除。
Science. 2016 Sep 2;353(6303):1045-1049. doi: 10.1126/science.aag0491. Epub 2016 Aug 18.
6
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.东非和泰国成人急性HIV-1感染的前瞻性研究。
N Engl J Med. 2016 Jun 2;374(22):2120-30. doi: 10.1056/NEJMoa1508952. Epub 2016 May 18.
7
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.一种新型急性HIV-1 C亚型gp145包膜寡聚体形式在临床前和临床疫苗研究中的可比抗原性和免疫原性
J Virol. 2015 Aug;89(15):7478-93. doi: 10.1128/JVI.00412-15. Epub 2015 May 13.
8
HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis.HIV-1进入SupT1-R5细胞、CEM-ss细胞和原代CD4+ T细胞是在质膜上发生的,且不需要内吞作用。
J Virol. 2014 Dec;88(24):13956-70. doi: 10.1128/JVI.01543-14. Epub 2014 Sep 24.
9
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.一种结合gp41-gp120界面的人源抗体对HIV-1具有广泛且强效的中和作用。
Nature. 2014 Nov 6;515(7525):138-42. doi: 10.1038/nature13601. Epub 2014 Sep 3.
10
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.广谱中和 HIV 抗体定义了 gp41 融合前构象上糖依赖性表位在裂解包膜三聚体上。
Immunity. 2014 May 15;40(5):657-68. doi: 10.1016/j.immuni.2014.04.009. Epub 2014 Apr 24.